News + Filings Transactions Holdings
|
venBio Global Strategic Fund III, L.P.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/09/2022 | Ventyx Biosciences, Inc. | | Grant | Stock Option (right to buy) | 13.3k | $16.54 | $220k | See footnote | 06/09/2022 |
| 06/09/2022 | Ventyx Biosciences, Inc. | | Grant | Stock Option (right to buy) | 13.3k | $16.54 | $220k | See footnote | 06/09/2022 |
| 05/25/2022 | Elevation Oncology, Inc. | ELEV | Sale | Common Stock | 702.7k | $4.12 | $2.9M | | 05/25/2022 |
| 10/25/2021 | Ventyx Biosciences, Inc. | | Conversion | Common Stock | 3.7M | $0.00 | $0 | | 10/25/2021 |
| 10/25/2021 | Ventyx Biosciences, Inc. | | Purchase | Common Stock | 312.5k | $16.00 | $5M | | 10/25/2021 |
| 10/25/2021 | Ventyx Biosciences, Inc. | | Conversion | Series A Preferred Stock | 3.3M | $0.00 | $0 | | 10/25/2021 |
| 10/25/2021 | Ventyx Biosciences, Inc. | | Conversion | Series B Preferred Stock | 395k | $0.00 | $0 | | 10/25/2021 |
| 06/29/2021 | Elevation Oncology, Inc. | ELEV | Conversion | Series B Preferred Stock | 8.4M | $0.00 | $0 | | 06/29/2021 |
| 06/29/2021 | Elevation Oncology, Inc. | ELEV | Purchase | Common Stock | 625k | $16.00 | $10M | | 06/29/2021 |
| 06/29/2021 | Elevation Oncology, Inc. | ELEV | Conversion | Common Stock | 2M | $0.00 | $0 | | 06/29/2021 |
|